Difference between revisions of "Team:Hong Kong-CUHK/Prototype"
| Line 29: | Line 29: | ||
<p><h1><b>Prototype</b></h1></p> | <p><h1><b>Prototype</b></h1></p> | ||
<p style="font-family: roboto;font-size:115%;"> | <p style="font-family: roboto;font-size:115%;"> | ||
| + | <br><br> | ||
| + | <h2><b>Marketing Research</b></h2> | ||
| + | <br><br> | ||
| + | Current point-of-care: | ||
| + | <br><br> | ||
| + | BD Veritor™ system1 cobasliat2 | ||
| + | <br><br> | ||
| + | Disadvantages: <br> | ||
| + | -Special machine is needed to show the results<br> | ||
| + | -Validated samples sources are restricted: only nasopharyngeal washes/aspirates and nasopharyngeal swabs | ||
| + | <br><br> | ||
| + | The advantage of our design: <br> | ||
| + | -Only heater/heat plate is needed<br> | ||
| + | -Even if no heater is available, incubated at room temperature for 12 hours can still show the result<br> | ||
| + | -Result is reported by colour changes, no special demonstrator is required <br> | ||
| + | -Throat swab is possible, increasing choice of sampling | ||
| + | <br><br> | ||
| + | Another benefit of our design is the involvement of subtyping test. None of the current commercial point-of-care kits is able to subtype the suspected samples, so subtyping mainly is handed over to analyzing laboratory. | ||
| + | <br><br> | ||
| + | Our kit is capable of subtyping …, providing an efficient way for frontline staff, such as immigration department and Agriculture, Fisheries and Conservation Department. | ||
<br><br> | <br><br> | ||
| + | |||
</body> | </body> | ||
Revision as of 18:06, 29 October 2017